OFATUMUMAB

ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device

OFATUMUMAB (12642J)

ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device
12642J
Body System:
Manner of administration:Injection
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 16323)

Indication: Multiple sclerosis
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 3 Max qty units: 3 # of repeats: 0 DPMQ: $6,337.80 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Kesimpta